Literature DB >> 29511324

Role of copy number variants in sudden cardiac death and related diseases: genetic analysis and translation into clinical practice.

Jesus Mates1, Irene Mademont-Soler1,2, Bernat Del Olmo1, Carles Ferrer-Costa3, Monica Coll1,2, Alexandra Pérez-Serra1,2, Ferran Picó1, Catarina Allegue1, Anna Fernandez-Falgueras1, Patricia Álvarez3, Raquel Yotti2,4, Maria Angeles Espinosa2,4, Georgia Sarquella-Brugada5, Sergi Cesar5, Ester Carro5, Josep Brugada2,5,6, Elena Arbelo2,6, Pablo Garcia-Pavia2,7, Mar Borregan8, Eduardo Tizzano8, Amador López-Granados9, Francisco Mazuelos9, Aranzazu Díaz de Bustamante10, Maria Teresa Darnaude10, José Ignacio González-Hevia11, Felícitas Díaz-Flores12, Francisco Trujillo13, Anna Iglesias1,2, Francisco Fernandez-Aviles2,4, Oscar Campuzano1,2,14, Ramon Brugada15,16,17,18.   

Abstract

Several studies have identified copy number variants (CNVs) as responsible for cardiac diseases associated with sudden cardiac death (SCD), but very few exhaustive analyses in large cohorts of patients have been performed, and they have been generally focused on a specific SCD-related disease. The aim of the present study was to screen for CNVs the most prevalent genes associated with SCD in a large cohort of patients who suffered sudden unexplained death or had an inherited cardiac disease (cardiomyopathy or channelopathy). A total of 1765 European patients were analyzed with a homemade algorithm for the assessment of CNVs using high-throughput sequencing data. Thirty-six CNVs were identified (2%), and most of them appeared to have a pathogenic role. The frequency of CNVs among cases of sudden unexplained death, patients with a cardiomyopathy or a channelopathy was 1.4% (8/587), 2.3% (20/874), and 2.6% (8/304), respectively. Detection rates were particularly high for arrhythmogenic cardiomyopathy (5.1%), long QT syndrome (4.7%), and dilated cardiomyopathy (4.4%). As such large genomic rearrangements underlie a non-neglectable portion of cases, we consider that their analysis should be performed as part of the routine genetic testing of sudden unexpected death cases and patients with SCD-related diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29511324      PMCID: PMC6018743          DOI: 10.1038/s41431-018-0119-1

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  29 in total

1.  Epidemiology and genetics of sudden cardiac death.

Authors:  Rajat Deo; Christine M Albert
Journal:  Circulation       Date:  2012-01-31       Impact factor: 29.690

2.  Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.

Authors:  L R Lopes; C Murphy; P Syrris; C Dalageorgou; W J McKenna; P M Elliott; V Plagnol
Journal:  Eur J Med Genet       Date:  2015-10-09       Impact factor: 2.708

3.  Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.

Authors:  Julien Barc; François Briec; Sébastien Schmitt; Florence Kyndt; Martine Le Cunff; Estelle Baron; Claude Vieyres; Frédéric Sacher; Richard Redon; Cédric Le Caignec; Hervé Le Marec; Vincent Probst; Jean-Jacques Schott
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

4.  Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy.

Authors:  Nadine Norton; Duanxiang Li; Mark J Rieder; Jill D Siegfried; Evadnie Rampersaud; Stephan Züchner; Steve Mangos; Jorge Gonzalez-Quintana; Libin Wang; Sean McGee; Jochen Reiser; Eden Martin; Deborah A Nickerson; Ray E Hershberger
Journal:  Am J Hum Genet       Date:  2011-02-25       Impact factor: 11.025

Review 5.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

6.  Assessment of LMNA copy number variation in 58 probands with dilated cardiomyopathy.

Authors:  Nadine Norton; Jill D Siegfried; Duanxiang Li; Ray E Hershberger
Journal:  Clin Transl Sci       Date:  2011-10       Impact factor: 4.689

7.  American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants.

Authors:  Hutton M Kearney; Erik C Thorland; Kerry K Brown; Fabiola Quintero-Rivera; Sarah T South
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

8.  CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.

Authors:  Eric Talevich; A Hunter Shain; Thomas Botton; Boris C Bastian
Journal:  PLoS Comput Biol       Date:  2016-04-21       Impact factor: 4.475

9.  Next generation sequencing-based copy number analysis reveals low prevalence of deletions and duplications in 46 genes associated with genetic cardiomyopathies.

Authors:  Ozge Ceyhan-Birsoy; Trevor J Pugh; Mark J Bowser; Elizabeth Hynes; Ashley L Frisella; Lisa M Mahanta; Matt S Lebo; Sami S Amr; Birgit H Funke
Journal:  Mol Genet Genomic Med       Date:  2015-12-16       Impact factor: 2.183

10.  Large Genomic Imbalances in Brugada Syndrome.

Authors:  Irene Mademont-Soler; Mel Lina Pinsach-Abuin; Helena Riuró; Jesus Mates; Alexandra Pérez-Serra; Mònica Coll; José Manuel Porres; Bernat Del Olmo; Anna Iglesias; Elisabet Selga; Ferran Picó; Sara Pagans; Carles Ferrer-Costa; Geòrgia Sarquella-Brugada; Elena Arbelo; Sergi Cesar; Josep Brugada; Óscar Campuzano; Ramon Brugada
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

View more
  5 in total

1.  The clinical utility of pediatric cardiomyopathy genetic testing: From diagnosis to a precision medicine-based approach to care.

Authors:  Lauren E Parker; Andrew P Landstrom
Journal:  Prog Pediatr Cardiol       Date:  2021-07-01

2.  Molecular Diagnosis of Inherited Cardiac Diseases in the Era of Next-Generation Sequencing: A Single Center's Experience Over 5 Years.

Authors:  Alexandre Janin; Louis Januel; Cécile Cazeneuve; Antoine Delinière; Philippe Chevalier; Gilles Millat
Journal:  Mol Diagn Ther       Date:  2021-05-05       Impact factor: 4.074

3.  Novel Indel Variation of NPC1 Gene Associates With Risk of Sudden Cardiac Death.

Authors:  Wenfeng Zhao; Qing Zhang; Jiawen Wang; Huan Yu; Xiaoyuan Zhen; Lijuan Li; Yan Qu; Yan He; Jianhua Zhang; Chengtao Li; Suhua Zhang; Bin Luo; Jiang Huang; Yuzhen Gao
Journal:  Front Genet       Date:  2022-04-11       Impact factor: 4.772

4.  Re-evaluation of single nucleotide variants and identification of structural variants in a cohort of 45 sudden unexplained death cases.

Authors:  Jacqueline Neubauer; Shouyu Wang; Giancarlo Russo; Cordula Haas
Journal:  Int J Legal Med       Date:  2021-04-25       Impact factor: 2.686

Review 5.  Clinical Genetics of Inherited Arrhythmogenic Disease in the Pediatric Population.

Authors:  Estefanía Martínez-Barrios; Sergi Cesar; José Cruzalegui; Clara Hernandez; Elena Arbelo; Victoria Fiol; Josep Brugada; Ramon Brugada; Oscar Campuzano; Georgia Sarquella-Brugada
Journal:  Biomedicines       Date:  2022-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.